A Case of Marburg Variant Multiple Sclerosis Treated With Rituximab

By afschroeder • September 23, 2025

Khamlong M, Saripalli A, Yan N, Bettencourt A, Sabetian K. A Case of Marburg Variant Multiple Sclerosis Treated With Rituximab. Cureus. 2025 Aug 21;17(8):e90698. doi: 10.7759/cureus.90698. PMID: 40984929; PMCID: PMC12450239.

Tags: fulminant multiple sclerosis, General Internal Medicine, immunosuppressant therapy, Kern, marburg variant, multiple sclerosis, neurology, Publications, Resident, rituximab

William J. Carroll, MD, FACP Appointed Section Chief of Palliative Care and Extensivist Medicine

The UCLA Department of Medicine (DoM) is pleased to announce the appointment of William J. Carroll, MD, FACPas section chief of the UCLA DoM Palliative Care[...]

Joshua N. Khalili, MD Appointed to DoM Chief Wellness Officer

The UCLA Department of Medicine has appointed Joshua N. Khalili, MD to chief wellness officer (CWO) effective April 1. The appointment builds on Dr. Khalili’s outstanding work[...]

Sun M. Yoo, MD, MPH to Depart DoM to Pursue New Leadership Opportunity

The UCLA Department of Medicine (DoM) announces that Sun M. Yoo, MD, MPH, will be departing UCLA Health to assume the role of a founding chief[...]